Cleavage of AL amyloid proteins and AL amyloid deposits by cathepsins B, K, and L

被引:46
作者
Bohne, S
Sletten, K
Menard, R
Bühling, F
Vöckler, S
Wrenger, E
Roessner, A
Röcken, C
机构
[1] Otto Von Guericke Univ, Inst Pathol, D-39120 Magdeburg, Germany
[2] Univ Oslo, Biotechnol Ctr Oslo, N-0316 Oslo, Norway
[3] Natl Res Council Canada, Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada
[4] Otto Von Guericke Univ, Inst Immunol, Magdeburg, Germany
[5] Otto Von Guericke Univ, Dept Internal Med, Div Nephrol, Magdeburg, Germany
关键词
amyloid; cysteine proteases; protease inhibitors;
D O I
10.1002/path.1553
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cathepsin (Cath) B, CathK and CathL are cysteine proteases that participate in the lysosomal protein degradation system and are expressed in macrophages, epithelioid cells, and multinucleated histiocytic giant cells (MGCs). Both macrophages and MGCs are commonly found adjacent to immunoglobulin light chain-associated (AL) amyloid deposits, which raised the question of whether cysteine proteases are able to cleave AL amyloid proteins and AL amyloid deposits. The present study has investigated whether recombinant human CathB, CathK, and CathL are able to degrade AL(VlambdaVI) amyloid proteins and AL amyloid deposits. Using immunohistochemistry, CathB, CathK, and CathL were found adjacent to AL amyloid deposits. In vitro degradation experiments using purified AL amyloid proteins showed that CathB,CathK, and CathL degrade AL(VlambdaVI) amyloid proteins. Furthermore, using unfixed tissue sections from an amyloidotic spleen as an in vitro model for extracellular proteolysis of intact amyloid deposits, it was demonstrated that all three cysteine proteases are also capable of degrading AL amyloid in situ. This is the first study to show that cysteine proteases are able to cleave AL amyloid proteins. However, the efficiency with which proteolysis occurs depends on the concentration of active protease recruited at the sites of amyloid deposition, and possibly on the structure of the AL amyloid proteins. Copyright (C) 2004 Pathological Society of Great Britain and Ireland. Published by John Wiley Sons, Ltd.
引用
收藏
页码:528 / 537
页数:10
相关论文
共 30 条
  • [11] GAMERO P, 1998, J BIOL CHEM, V273, P32347
  • [12] Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency
    Gelb, BD
    Shi, GP
    Chapman, HA
    Desnick, RJ
    [J]. SCIENCE, 1996, 273 (5279) : 1236 - 1238
  • [13] Antibody-mediated resolution of light chain-associated amyloid deposits
    Hrncic, R
    Wall, J
    Wolfenbarger, DA
    Murphy, CL
    Schell, M
    Weiss, DT
    Solomon, A
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2000, 157 (04) : 1239 - 1246
  • [14] In vitro modulation of AL-amyloid formation by human mesangial cells exposed to amyloidogenic light chains
    Isaac, J
    Kerby, JD
    Russell, WJ
    Dempsey, SC
    Sanders, PW
    Herrera, GA
    [J]. AMYLOID-INTERNATIONAL JOURNAL OF EXPERIMENTAL AND CLINICAL INVESTIGATION, 1998, 5 (04): : 238 - 246
  • [15] EFFECT OF PAPAIN, PRONASE, NAGARSE AND TRYPSIN ON ISOLATED AMYLOID FIBRILS
    KIM, IC
    FRANZBLAU, C
    SHIRAHAMA, T
    COHEN, AS
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1969, 181 (02) : 465 - +
  • [16] Distribution pattern of matrix metalloproteinases 1, 2, 3, and 9, tissue inhibitors of matrix metalloproteinases 1 and 2, and α2-macroglobulin in cases of generalized AA- and AL amyloidosis
    Müller, D
    Roessner, A
    Röcken, C
    [J]. VIRCHOWS ARCHIV, 2000, 437 (05) : 521 - 527
  • [17] Regulation of elastinolytic cysteine proteinase activity in normal and cathepsin K-deficient human macrophages
    Punturieri, A
    Filippov, S
    Allen, E
    Caras, I
    Murray, R
    Reddy, V
    Weiss, SJ
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (06) : 789 - 799
  • [18] PERICELLULAR MOBILIZATION OF THE TISSUE-DESTRUCTIVE CYSTEINE PROTEINASES, CATHEPSIN-B, CATHEPSIN-L, AND CATHEPSIN-S, BY HUMAN MONOCYTE-DERIVED MACROPHAGES
    REDDY, VY
    ZHANG, QY
    WEISS, SJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (09) : 3849 - 3853
  • [19] Röcken C, 1999, J HISTOCHEM CYTOCHEM, V47, P1385
  • [20] Advanced glycation end products and receptor for advanced glycation end products in AA amyloidosis
    Röcken, C
    Kientsch-Engel, R
    Mansfeld, S
    Stix, B
    Stubenrauch, K
    Weigle, B
    Bühling, F
    Schwan, M
    Saeger, W
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2003, 162 (04) : 1213 - 1220